Joseph Shulman - Net Worth and Insider Trading

Joseph Shulman Net Worth

The estimated net worth of Joseph Shulman is at least $737,730 dollars as of 2025-07-12. Joseph Shulman is the Chief Technical Officer of Rhythm Pharmaceuticals Inc and owns about 8,509 shares of Rhythm Pharmaceuticals Inc (RYTM) stock worth over $737,730. Details can be seen in Joseph Shulman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph Shulman has not made any transactions after 2025-07-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Joseph Shulman

To

Joseph Shulman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph Shulman owns 1 companies in total, including Rhythm Pharmaceuticals Inc (RYTM) .

Click here to see the complete history of Joseph Shulman’s form 4 insider trades.

Insider Ownership Summary of Joseph Shulman

Ticker Company Transaction Date Type of Owner
RYTM Rhythm Pharmaceuticals Inc 2025-07-09 Chief Technical Officer

Joseph Shulman Latest Holdings Summary

Joseph Shulman currently owns a total of 1 stock. Joseph Shulman owns 8,509 shares of Rhythm Pharmaceuticals Inc (RYTM) as of July 9, 2025, with a value of $737,730.

Latest Holdings of Joseph Shulman

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RYTM Rhythm Pharmaceuticals Inc 2025-07-09 8,509 86.70 737,730

Holding Weightings of Joseph Shulman


Joseph Shulman Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph Shulman has made a total of 20 transactions in Rhythm Pharmaceuticals Inc (RYTM) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Rhythm Pharmaceuticals Inc is the sale of 7,969 shares on July 9, 2025, which brought Joseph Shulman around $619,829.

Insider Trading History of Joseph Shulman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph Shulman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Joseph Shulman Ownership Network

Ownership Network List of Joseph Shulman

No Data

Ownership Network Relation of Joseph Shulman

Insider Network Chart


Joseph Shulman Owned Company Details

What does Rhythm Pharmaceuticals Inc do?

Who are the key executives at Rhythm Pharmaceuticals Inc?

Joseph Shulman is the Chief Technical Officer of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Corporate Controller & CAO Christopher Paul German , Chief Human Resources Officer Pamela J. Cramer , and CFO and Treasurer Hunter C Smith .

Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary

Over the past 18 months, Joseph Shulman made 14 insider transaction in Rhythm Pharmaceuticals Inc (RYTM) with a net sale of 155,853. Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 137,211 shares made by Pamela J. Cramer , a net sale of 118,525 shares made by Jennifer Chien , and a net sale of 90,509 shares made by Hunter C Smith .

In summary, during the past 3 months, insiders sold 226,124 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 226,124 shares. During the past 18 months, 920,276 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 920,276 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rhythm Pharmaceuticals Inc Insider Transactions

No Available Data

Joseph Shulman Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph Shulman. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Joseph Shulman's mailing address is: Boston Ma 02116.